Announcements Trials
Browse Landscape

Status

Enrolling by invitation 1

Sponsor Class

NIH 1

Study Type

Interventional 27Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia 1

Interventions

Blood Specimen Collection 53Surveys and Questionnaires 49Specimen Handling 29Observation 15Radiotherapy 14Magnetic Resonance Spectroscopy 12Surgical Procedures, Operative 11Interviews as Topic 11Data Collection 11Drug Therapy 9darolutamide 8Biopsy 8palbociclib 7Watchful Waiting 7Tomography, X-Ray Computed 7Standard of Care 7ribociclib 6Magnetic Resonance Imaging 6Bevacizumab 6trastuzumab deruxtecan 5Ultrasonography 5Restraint, Physical 5Radiofrequency Ablation 5Patient Reported Outcome Measures 5Mental Status and Dementia Tests 5Mastectomy, Segmental 5Mass Screening 5Genetic Testing 5Breath Tests 5enzalutamide 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Leukapheresis × 90 days × Clear all
NCT03226704 2026-05-20

Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing

National Institutes of Health Clinical Center (CC)

Enrolling by invitation
120 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡